Atlas Trials

Investigating the Adjunctive Use of Mirabegron in the Early Post-Rezum Procedure Period

Clinical trial NCT07017439 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07017439
Sponsor
University of Manitoba
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Benign Prostate Hypertrophy(BPH)
Start date
2025-08-01
Primary completion
2025-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.